What is AIRWAYS-3?

AIRWAYS-3 is a clinical study to find the best way for hospital staff to keep a patient’s airway open so artificial breathing can be given during a cardiac arrest. We are comparing two methods that are currently used routinely in NHS care.

Why would I or my relative have been entered into the study?

When someone has a cardiac arrest, treatment must start immediately. This means it isn’t possible to ask permission from the patient or family member before the patient is entered in the study. This is in keeping with the legal and ethical regulations that apply to research of this type.

We are committed to continually improving care and treatment for patients. We know that an event like this is always difficult, however, what we learn from your/their involvement in this study may help future patients who are affected by cardiac arrest.

What will you do with my information if I or my relative takes part?

We will need to use information from your or your relatives medical records for this clinical study.

This will include name, date of birth, NHS number and contact details (address and telephone number). Our team will use this information to carry out the research or to check your records to make sure that the research is being completed as planned. Only those people who need to know who you are will be able to see your name or contact details. The rest of your information will be identified by a code number. We will keep all information about you safe and secure.

What are my choices about how my information is used?

• You can stop being part of the study at any time, without giving a reason, but we will keep information about you that we already have.
• We need to manage your records in specific ways for the research to be reliable. This means that we won’t be able to let you see or change the data we hold about you.

To find out more about how your data is used and kept safe, your rights under the General Data Protection Regulation (GDPR) and the Information Commissioner’s Office complaints procedure please contact the study team using the details on page one. The University Hospitals Bristol and Weston NHS Foundation Trust (UHBW) are the sponsor for AIRWAYS-3, and are joint study data controllers with the University of Warwick which is managing the trial. They are both responsible for looking after your information.

You can find out more about how we use your information:

• at hra.nhs.uk/information-about-patients/,
• the leaflet available from hra.nhs.uk/patientdataandresearch
• by asking one of the research team or by using the contact details on the first page.
• Privacy notices that describe the legal basis, ICO complaints procedure and how to exercise your rights under GDPR can be found at:

• UHBW NHS - What we do with your data
• by sending an email to the University of Warwick Data Protection Officer: researchgovernance@warwick.ac.uk

 

Will my taking part be kept confidential?

Once we have finished the study, we will keep some of the information so we can check the results. We will write our reports in a way that no-one will know you took part in the study.

The University Hospitals Bristol and Weston NHS Foundation Trust, the University of Warwick and all hospitals taking part in the study will keep information about you for 10 years after the study has finished so we can check the results. Your name and contact details will be deleted as soon as they are no longer needed.

What will happen to the results of the research study?

The study is expected to take around four years to complete. We will share the results of the study with other healthcare professionals and publish the results in medical journals. When any information from the study is published it will not contain personal information, and it will not be possible to identify you in any way. We will do our best to make sure the results of the study are shared widely, and they will be made available on our website at https://www.warwick.ac.uk/airways3.

Who is organising and funding the study? Who has reviewed it?

The study is organised by a group of doctors and scientists led by Professor Jonathan Benger, who works at the University Hospitals Bristol and Weston NHS Foundation Trust. All research in the NHS is reviewed by an independent group of people, called a Research Ethics Committee, to protect your safety, rights, wellbeing and dignity. This study was reviewed and given a favourable opinion by the Wales 1 REC on 22^nd July 2022. The Study has also been reviewed by the Health Research Authority (HRA) and National Institute for Health and Care Research (NIHR).

What happens if I have any questions?

Please refer to the detailed information leaflet described above. If you would like further information, you can contact the study team as follows:

Email: airways3@warwick.ac.uk

Address: AIRWAYS-3 Trial Manager, Warwick Clinical Trials Unit, Warwick Medical School,

University of Warwick, Coventry. CV4 7AL

Phone: 02476572905 or 07385083320

Contact Trial Team

Email:

airways3@warwick.ac.uk

Address:

AIRWAYS3 Trial Manager,
Warwick Clinical Trials Unit,
Warwick Medical School,
University of Warwick,
Coventry.
CV4 7AL

CTU Trial Team Members

Trial Manager - Jannat Chowdhury

Trial Co-ordinator - Emmanuel Abimbola

Data Entry Clerk - Laurilee Sprauve